Compass (COMP)
(Delayed Data from NYSE)
$3.30 USD
+0.08 (2.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.30 0.00 (0.00%) 7:28 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
COMP 3.30 +0.08(2.48%)
Will COMP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for COMP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COMP
Compass, Inc. (COMP) Reports Q2 Loss, Misses Revenue Estimates
Compass, Inc. (COMP) Reports Q1 Loss, Tops Revenue Estimates
COMP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compass, Inc. (COMP) Reports Q4 Loss, Lags Revenue Estimates
Are Computer and Technology Stocks Lagging Fastly (FSLY) This Year?
Garmin (GRMN) to Report Q4 Earnings: What's in the Cards?
Other News for COMP
Berkshire Hathaway's property brokerage to pay $250M to settle commission suits
DA Davidson real estate analysts hold analyst/industry conference call
Compass to Announce First Quarter 2024 Earnings on Wednesday, May 8
Benitec Biopharma reports positive data in early study for OPMD treatment
Medical Properties Trust in real estate gainers, Compass in losers